Ken Griffin’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Buy
431,809
+144,526
+50% +$827K ﹤0.01% 6057
2025
Q4
$2.24M Buy
287,283
+115,740
+67% +$989K ﹤0.01% 5701
2025
Q3
$1.43M Sell
171,543
-947,218
-85% -$8M ﹤0.01% 6767
2025
Q2
$7.94M Buy
1,118,761
+16,039
+1% +$119K ﹤0.01% 3369
2025
Q1
$9.65M Buy
1,102,722
+723,712
+191% +$7.62M ﹤0.01% 2896
2024
Q4
$4.79M Sell
379,010
-350,221
-48% -$4.22M ﹤0.01% 4034
2024
Q3
$8.17M Buy
729,231
+315,991
+76% +$3.7M ﹤0.01% 3220
2024
Q2
$5.3M Buy
413,240
+220,051
+114% +$3.36M ﹤0.01% 3659
2024
Q1
$3.02M Sell
193,189
-211,121
-52% -$3.33M ﹤0.01% 4779
2023
Q4
$6.66M Buy
404,310
+255,812
+172% +$3.56M ﹤0.01% 3402
2023
Q3
$1.79M Buy
148,498
+88,409
+147% +$1.19M ﹤0.01% 5421
2023
Q2
$856K Sell
60,089
-8,479
-12% -$124K ﹤0.01% 6784
2023
Q1
$1.06M Sell
68,568
-248,720
-78% -$4.03M ﹤0.01% 6645
2022
Q4
$5.53M Buy
317,288
+151,576
+91% +$2.25M ﹤0.01% 3684
2022
Q3
$2.11M Sell
165,712
-57,188
-26% -$762K ﹤0.01% 5487
2022
Q2
$2.53M Buy
222,900
+36,233
+19% +$344K ﹤0.01% 5077
2022
Q1
$1.94M Sell
186,667
-201,549
-52% -$2.73M ﹤0.01% 6146
2021
Q4
$6.23M Buy
388,216
+253,342
+188% +$3.98M ﹤0.01% 3907
2021
Q3
$1.93M Buy
134,874
+30,008
+29% +$428K ﹤0.01% 6445
2021
Q2
$1.64M Buy
104,866
+12,237
+13% +$197K ﹤0.01% 7104
2021
Q1
$1.55M Buy
92,629
+42,146
+83% +$689K ﹤0.01% 7019
2020
Q4
$777K Sell
50,483
-148,526
-75% -$2.19M ﹤0.01% 7310
2020
Q3
$2.54M Buy
199,009
+74,670
+60% +$962K ﹤0.01% 4277
2020
Q2
$1.78M Buy
124,339
+26,612
+27% +$389K ﹤0.01% 4783
2020
Q1
$1.21M Buy
+97,727
New +$1.87M ﹤0.01% 4994
2019
Q4
Sell
-31,831
Closed -$653K 9054
2019
Q3
$622K Sell
31,831
-112,519
-78% -$2.07M ﹤0.01% 6385
2019
Q2
$2.43M Buy
144,350
+47,319
+49% +$808K ﹤0.01% 4183
2019
Q1
$1.76M Buy
97,031
+57,413
+145% +$1.1M ﹤0.01% 4678
2018
Q4
$683K Sell
39,618
-36,415
-48% -$669K ﹤0.01% 5919
2018
Q3
$1.55M Buy
76,033
+42,646
+128% +$890K ﹤0.01% 4817
2018
Q2
$663K Buy
33,387
+3,023
+10% +$55.8K ﹤0.01% 5910
2018
Q1
$476K Buy
30,364
+11,973
+65% +$185K ﹤0.01% 5956
2017
Q4
$294K Sell
18,391
-69,606
-79% -$1.07M ﹤0.01% 6497
2017
Q3
$1.52M Buy
87,997
+31,318
+55% +$578K ﹤0.01% 3749
2017
Q2
$984K Buy
+56,679
New +$1.01M ﹤0.01% 4096
2017
Q1
Sell
-58,520
Closed -$1.23M 7388
2016
Q4
$1.32M Buy
+58,520
New +$1.28M ﹤0.01% 3470
2016
Q2
Sell
-90,897
Closed -$1.44M 6775
2016
Q1
$1.44M Sell
90,897
-104,342
-53% -$1.51M ﹤0.01% 3038
2015
Q4
$2.75M Sell
195,239
-290,284
-60% -$4.46M ﹤0.01% 2423
2015
Q3
$7.03M Buy
485,523
+181,040
+59% +$2.94M 0.01% 1611
2015
Q2
$5.07M Buy
304,483
+159,724
+110% +$3.77M ﹤0.01% 2056
2015
Q1
$3.5M Buy
144,759
+924
+0.6% +$23.5K ﹤0.01% 2414
2014
Q4
$3.52M Buy
143,835
+100,243
+230% +$2.33M ﹤0.01% 2309
2014
Q3
$963K Buy
43,592
+14,640
+51% +$344K ﹤0.01% 3742
2014
Q2
$791K Sell
28,952
-4,029
-12% -$117K ﹤0.01% 3798
2014
Q1
$1.02M Sell
32,981
-14,560
-31% -$402K ﹤0.01% 3384
2013
Q4
$1.17M Buy
47,541
+7,284
+18% +$153K ﹤0.01% 3070
2013
Q3
$730K Sell
40,257
-54,062
-57% -$1.23M ﹤0.01% 3412
2013
Q2
$2.25M Buy
+94,319
New +$2.29M ﹤0.01% 2382

Other funds holding OSG

Ken Griffin's OSG Position: Q1 2026 in Review

Ken Griffin increased its Octave Specialty Group (OSG) stake by 50% in Q1 2026, buying an estimated $827K and bringing the position to 431,809 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #6057.

Ken Griffin first reported a position in OSG in Q2 2013 and has held it in 48 quarters since. The position peaked at $9.65M in Q1 2025. 148 funds tracked by Wall St. Rank hold OSG as of Q1 2026.

  • Ken Griffin held 431,809 shares of Octave Specialty Group worth $2.01M as of Q1 2026.
  • Ken Griffin bought 144,526 Octave Specialty Group shares in Q1 2026, an estimated $827K.
  • Octave Specialty Group made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #6057 holding.
  • Ken Griffin first reported a position in Octave Specialty Group in Q2 2013 and has held it in 48 quarters since.
  • Ken Griffin's Octave Specialty Group position peaked at $9.65M in Q1 2025.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.